Durect In NASH, And The Market Assessment [Seeking Alpha]
DURECT Corporation (DRRX)
Last durect corporation earnings: 3/3 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
durect.com/investors
Company Research
Source: Seeking Alpha
Durect In NASH, And The Market Assessment Summary Liver Therapy Forum weekly digest provides an overview on what’s happening in the NASH ecosystem in Q1/2019. We take a look at Durect for the latest development on its new NASH program. Durect recently announced that it was initiating a Phase 1b clinical trial of DUR-928 in NASH in Q1/2019, with data readout expected in Q2/2019. Overall, this weekly newsletter provides news-related events on stocks focused on the development of liver therapeutics. Market Assessment In Q1/2019, DUR-928, the lead investigative drug candidate for Durect ( DRRX I look at how the market may be evaluating the clinical prospect of DUR-928 with emphasis on institutional investor purchases and analyst ratings. Institutional Investors, Insiders Purchase And Analyst Ratings latest 13F filings three analyst firms 12-month consensus ALD recent decision Based on the percent of Institutional interest, I believe that if there's perceived clinical efficacy for DUR-928
Show less
Read more
Impact Snapshot
Event Time:
DRRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRRX alerts
High impacting DURECT Corporation news events
Weekly update
A roundup of the hottest topics
DRRX
News
- DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.MarketBeat
- DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.MarketBeat
- Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
DRRX
Earnings
- 3/27/24 - Beat
DRRX
Sec Filings
- 3/28/24 - Form 424B5
- 3/28/24 - Form 10-K
- 3/27/24 - Form 8-K
- DRRX's page on the SEC website